SRPT Q2 2019 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$95M+28.7% YoY

Gross Profit

$79M83.2% margin

Operating Income

-$275M-290.9% margin

Net Income

-$276M-292.0% margin

EPS (Diluted)

$-3.74

QoQ Revenue Growth

+8.8%

Cash Flow

Operating Cash Flow

-$79M

Free Cash Flow

-$96M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$649M

Stockholders' Equity

$1.1B

Cash & Equivalents

$809M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$95M	$74M	+28.7%
Gross Profit	$79M	$67M	+17.9%
Operating Income	-$275M	-$103M	-166.2%
Net Income	-$276M	-$109M	-153.0%